• Je něco špatně v tomto záznamu ?

Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids

VK. Nelson, MV. Nuli, J. Mastanaiah, M. Saleem T S, G. Birudala, YF. Jamous, O. Alshargi, KK. Kotha, HH. Sudhan, RR. Mani, A. Muthumanickam, D. Niranjan, NK. Jain, A. Agrawal, AS. Jadon, V. Mayasa, NK. Jha, A. Kolesarova, P. Slama, S. Roychoudhury

. 2023 ; 14 (-) : 1201198. [pub] 20230725

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016824

Colorectal cancer (CRC) is one of the most deaths causing diseases worldwide. Several risk factors including hormones like insulin and insulin like growth factors (e.g., IGF-1) have been considered responsible for growth and progression of colon cancer. Though there is a huge advancement in the available screening as well as treatment techniques for CRC. There is no significant decrease in the mortality of cancer patients. Moreover, the current treatment approaches for CRC are associated with serious challenges like drug resistance and cancer re-growth. Given the severity of the disease, there is an urgent need for novel therapeutic agents with ideal characteristics. Several pieces of evidence suggested that natural products, specifically medicinal plants, and derived phytochemicals may serve as potential sources for novel drug discovery for various diseases including cancer. On the other hand, cancer cells like colon cancer require a high basal level of reactive oxygen species (ROS) to maintain its own cellular functions. However, excess production of intracellular ROS leads to cancer cell death via disturbing cellular redox homeostasis. Therefore, medicinal plants and derived phytocompounds that can enhance the intracellular ROS and induce apoptotic cell death in cancer cells via modulating various molecular targets including IGF-1 could be potential therapeutic agents. Alkaloids form a major class of such phytoconstituents that can play a key role in cancer prevention. Moreover, several preclinical and clinical studies have also evidenced that these compounds show potent anti-colon cancer effects and exhibit negligible toxicity towards the normal cells. Hence, the present evidence-based study aimed to provide an update on various alkaloids that have been reported to induce ROS-mediated apoptosis in colon cancer cells via targeting various cellular components including hormones and growth factors, which play a role in metastasis, angiogenesis, proliferation, and invasion. This study also provides an individual account on each such alkaloid that underwent clinical trials either alone or in combination with other clinical drugs. In addition, various classes of phytochemicals that induce ROS-mediated cell death in different kinds of cancers including colon cancer are discussed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016824
003      
CZ-PrNML
005      
20231026105522.0
007      
ta
008      
231013s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fendo.2023.1201198 $2 doi
035    __
$a (PubMed)37560308
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Nelson, Vinod K $u Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India
245    10
$a Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids / $c VK. Nelson, MV. Nuli, J. Mastanaiah, M. Saleem T S, G. Birudala, YF. Jamous, O. Alshargi, KK. Kotha, HH. Sudhan, RR. Mani, A. Muthumanickam, D. Niranjan, NK. Jain, A. Agrawal, AS. Jadon, V. Mayasa, NK. Jha, A. Kolesarova, P. Slama, S. Roychoudhury
520    9_
$a Colorectal cancer (CRC) is one of the most deaths causing diseases worldwide. Several risk factors including hormones like insulin and insulin like growth factors (e.g., IGF-1) have been considered responsible for growth and progression of colon cancer. Though there is a huge advancement in the available screening as well as treatment techniques for CRC. There is no significant decrease in the mortality of cancer patients. Moreover, the current treatment approaches for CRC are associated with serious challenges like drug resistance and cancer re-growth. Given the severity of the disease, there is an urgent need for novel therapeutic agents with ideal characteristics. Several pieces of evidence suggested that natural products, specifically medicinal plants, and derived phytochemicals may serve as potential sources for novel drug discovery for various diseases including cancer. On the other hand, cancer cells like colon cancer require a high basal level of reactive oxygen species (ROS) to maintain its own cellular functions. However, excess production of intracellular ROS leads to cancer cell death via disturbing cellular redox homeostasis. Therefore, medicinal plants and derived phytocompounds that can enhance the intracellular ROS and induce apoptotic cell death in cancer cells via modulating various molecular targets including IGF-1 could be potential therapeutic agents. Alkaloids form a major class of such phytoconstituents that can play a key role in cancer prevention. Moreover, several preclinical and clinical studies have also evidenced that these compounds show potent anti-colon cancer effects and exhibit negligible toxicity towards the normal cells. Hence, the present evidence-based study aimed to provide an update on various alkaloids that have been reported to induce ROS-mediated apoptosis in colon cancer cells via targeting various cellular components including hormones and growth factors, which play a role in metastasis, angiogenesis, proliferation, and invasion. This study also provides an individual account on each such alkaloid that underwent clinical trials either alone or in combination with other clinical drugs. In addition, various classes of phytochemicals that induce ROS-mediated cell death in different kinds of cancers including colon cancer are discussed.
650    _2
$a lidé $7 D006801
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a insulinu podobný růstový faktor I $7 D007334
650    12
$a nádory tračníku $x farmakoterapie $x metabolismus $7 D003110
650    12
$a alkaloidy $x terapeutické užití $7 D000470
650    _2
$a hormony $x terapeutické užití $7 D006728
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Nuli, Mohana Vamsi $u Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India
700    1_
$a Mastanaiah, Juturu $u Department of Pharmacology, Balaji College of Pharmacy, Anantapur, India
700    1_
$a Saleem T S, Mohamed $u College of Pharmacy, Riyadh ELM University, Riyadh, Saudi Arabia
700    1_
$a Birudala, Geetha $u Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, Chennai, India
700    1_
$a Jamous, Yahya F $u Vaccines and Bioprocessing Centre, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia
700    1_
$a Alshargi, Omar $u College of Pharmacy, Riyadh ELM University, Riyadh, Saudi Arabia
700    1_
$a Kotha, Kranthi Kumar $u Department of Pharmaceutics, College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, India
700    1_
$a Sudhan, Hari Hara $u Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India
700    1_
$a Mani, Ravishankar Ram $u Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia
700    1_
$a Muthumanickam, Alagusundaram $u School of Pharmacy, ITM University, Gwalior, India
700    1_
$a Niranjan, Divya $u School of Pharmacy, ITM University, Gwalior, India
700    1_
$a Jain, Nem Kumar $u School of Pharmacy, ITM University, Gwalior, India
700    1_
$a Agrawal, Ankur $u School of Pharmacy, ITM University, Gwalior, India
700    1_
$a Jadon, Arvind Singh $u Amity Institute of Pharmacy, Amity University, Gwalior, India
700    1_
$a Mayasa, Vinyas $u GITAM School of Pharmacy, GITAM University Hyderabad Campus, Rudraram, India
700    1_
$a Jha, Niraj Kumar $u Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India $u Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, India $u School of Bioengineering & Biosciences, Lovely Professional University, Phagwara, India $u Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali, India
700    1_
$a Kolesarova, Adriana $u Faculty of Biotechnology and Food Sciences, Slovak University of Agriculture in Nitra, Nitra, Slovakia
700    1_
$a Slama, Petr $u Laboratory of Animal Immunology and Biotechnology, Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, Brno, Czechia
700    1_
$a Roychoudhury, Shubhadeep $u Department of Life Science and Bioinformatics, Assam University, Silchar, India
773    0_
$w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 14, č. - (2023), s. 1201198
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37560308 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105516 $b ABA008
999    __
$a ok $b bmc $g 2000393 $s 1203186
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 14 $c - $d 1201198 $e 20230725 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace